Gut and oral microbiota in autoimmune liver disease

Kazumichi Abe; Masashi Fujita; Manabu Hayashi; Ken Okai; Atsushi Takahashi; Hiromasa Ohira

doi:10.5387/fms.2019-21

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Gut and oral microbiota in autoimmune liver disease

Kazumichi Abe, Masashi Fujita, Manabu Hayashi, Ken Okai, Atsushi Takahashi, Hiromasa Ohira

著者情報

キーワード: gut microbiota, oral microbiota, autoimmune hepatitis, primary biliary cholangitis

ジャーナルオープンアクセス HTML 早期公開

論文ID: 2019-21

DOI https://doi.org/10.5387/fms.2019-21

この記事には本公開記事があります。

The final version of this article is now available: Vol. 65 (2019), No. 3 pp. 71-75

詳細

抄録

The gut microbiota plays a key role in the development of chronic inflammatory liver disease. The gut-liver axis involves inflammatory cells, cytokines, and other molecules that cause liver deterioration. Dysbiosis is important in understanding several liver diseases, especially in relation to the development of autoimmune liver disease. The aim of this review is to provide a current overview of alterations in the gut and oral microbiota associated with autoimmune liver diseases.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）